SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Immunomedics (IMMU) - moderated
An SI Board Since September 2006
Posts SubjectMarks Bans Symbol
63376 356 15 IMMU
Emcee:  idahoranch1 Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
62043CBAY press release: CymaBay Initiates AFFIRM, a Phase 3b/4 Study Evaluating theerickerickson19/21/2023
62042AUPH and MKT capital... AURINIA BOARD OF DIRECTORS APPOINTS DR. ROBERT T. FOSTEerickerickson19/21/2023
62041Cassava Sciences Announces Positive Interim Safety Review of Simufilam On-going erickerickson39/18/2023
62040For those who follow AVXL anavex.comOlecranon29/15/2023
62039CBAY closes offering. That was fast... CymaBay Announces Closing of Upsized $25erickerickson39/15/2023
62038CBAY and Avoro: Form 4 Summary (transaction dates 12 and 13 Sep) - 3,000 put cerickerickson79/14/2023
62037CymaBay Announces Pricing of Upsized $225 Million Public Offering of Common Stocerickerickson79/12/2023
62036To be clear: Drs. Wang/Burns received an "Expression of Concern" on a ghettogoulash-9/12/2023
62035I'm pretty sure this was the data Lindsay was so happy about last month in aghettogoulash-9/12/2023
62034Speaking of reproducibility, where's Li? We just got it... two years later. ghettogoulash-9/12/2023
62033Gilead’s Phase 2 EVOKE-02 Study of Trodelvy® (sacituzumab govitecan-hziy) idorightbythem39/11/2023
62032E It may move slightly, but I agree this has, and will continue to be, a binary Davidoff19/11/2023
62031SAVA announcement: You beat me to it. Here's the title: "Cassava Scieerickerickson49/11/2023
62030SAVA cassavasciences.comDavidoff19/11/2023
62029CBAY offers $150,000,000 of Shares of Common Stock and Pre-Funded Warrants to Puerickerickson29/11/2023
62028On September 7, 2023, Ed Arce, an analyst at HC Wainwright & Co., expressed dorightbythem19/8/2023
62027Great news for CBAY! Call noted that they were already ramping up for FDA UE andCFL Invest 119/8/2023
62026My savant sold my 10,000 CBAY at $13.5. He says we're no longer looking for EMU2-9/7/2023
62025CBAY: It was down $5 when I was writing that post, roughly 7:00 give or take. Serickerickson-9/7/2023
62024OMG... at 6:45 this morning, EST, I watched as CBAY went from $16+ down to $8.48summer_sky-9/7/2023
62023When was it down $5? Before the PR? I'm back in (halfway) at $14.80.ghettogoulash-9/7/2023
62022Looks like CBAY is on its way! Great #’s and guidance to get FDA, EU, Japan apprCFL Invest 129/7/2023
62021CymaBay's Seladelpar Achieves High Statistical Significance for the Primary erickerickson39/7/2023
62020ir.cymabay.comdrtom123439/7/2023
62019DBGI: As I have said before, I would prefer to see the stock lay low for the nexghettogoulash-9/6/2023
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News